Bullboard Post History

The Call

Diagnocure's call just ended and there were good points made by...

U.S. shares traded

12,400 shares traded today in the U.S. under dgcrf. I was wrong when I posted...

RE: Now That's Liquidity...800 shares traded

It has been since 6/20/08 that it traded less shares, 600. I keep feeling...

52 week high

I have read about the PCA3 study in at least 15 to 20 different papers this...

any opinions on Study?

RE: AUA study released

Here were the words that I liked to see; "these results will help...

Reuters story on study

Urine test improves prostate diagnosis - study Tue Jun...

AUA study released

AUA 2010 - PCA3, A urine test for prostate cancer, shows increased...

AUA

If I am reading the program correctly, it looks like PCA3 should be discussed...

RE: AUA program page 11

correction, page 13

AUA program page 11

The AUA program has a full page PCA3 ad from Gen-Probe http://www.aua2010...

FDA Trial Completed

Well, I said I would not post but this is worth it. Clinical Evaluation of...

The buy side

I want to start off by saying that its a difficult market overall, but, its...

market depth

I continue to watch market depth, more than I should, and I see...

RE: RE: Dance with the Ugly Ones

I agree with what has been said but what hurts CUR is the lack of news flow...

buyers are there

I continue to see the the bid volume increase but the current group of...

RE: Biotech buyout candidate report

We would all like to see the share price start moving prior to any talk about...

U.S. adoption (PCA3)

Gen-Probe is making big strides here in the States; its clear that they are...

New Study

The PCA3 Assay improves the prediction of initial biopsy outcome and may be...

market timing

In my opinion, this month will be the last time we see CUR under $2.00.